1. Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2. The role of sugars in dendritic cell trafficking.;Silva;Ann. Biomed. Eng.,2012
3. Dana-Farber Cancer Institute; National Cancer Institute. 2004. Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma. In: ClinicalTrials.gov. National Library of Medicine (US), Bethesda, MD. NLM Identifier: NCT00085397. Available at: https://clinicaltrials.gov/ct2/show/NCT00085397?cond=NCT00085397&rank=1. Accessed: June 13, 2018.
4. Northwest Biotherapeutics. 2002. Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (GBM). In ClinicalTrials.gov. National Library of Medicine (US), Bethesda, MD. NLM Identifier: NCT00045968. Available at: https://clinicaltrials.gov/ct2/show/NCT00045968?cond=NCT00045968&rank=1. Accessed: June 13, 2018.
5. Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Brigham and Women's Hospital; Rambam Health Care Campus; Gateway for Cancer Research; United States Department of Defense. 2010. Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation. In ClinicalTrials.gov. National Library of Medicine (US), Bethesda, MD. NLM Identifier: NCT01067287. Available at: https://clinicaltrials.gov/ct2/show/NCT01067287?cond=NCT01067287&rank=1. Accessed: June 13, 2018.